Full text
Earnings transcript
Read the complete earnings call transcript.
FMC
FMC Corporation
$11.33
0.67
(6.29%)
| Exchange: | NYSE |
| Market Cap: | 1.419B |
| Shares Outstanding: | 180.144M |
Delayed data
About The Company
| Sector: | Basic Materials | |||||
| Industry: | Agricultural Inputs | |||||
| CEO: | Pierre R. Brondeau | |||||
| Full Time Employees: | 5500 | |||||
| Address: |
| |||||
| Website: | https://www.fmc.com |
FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The company is responsible for creating, commercializing, and selling various crop protection chemicals, including insecticides, herbicides, and fungicides, alongside biologicals, crop nutrition supplements, and seed treatment solutions. These innovations are employed in farming to boost harvest quantity and quality by mitigating diverse insect infestations, weed growth, and plant ailments. Furthermore, its solutions cater to non-agricultural sectors for general pest control. FMC distributes its comprehensive product range through its proprietary sales teams, in collaboration with alliance partners, and via independent distributors and sales representatives. Established in 1883, FMC Corporation is based in Philadelphia, Pennsylvania, and conducts operations across North America, Latin America, Europe, the Middle East, Africa, and Asia.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 4,486,800 | 4,246,100 | 3,467,400 |
| Gross Profit | 1,908,300 | 1,577,300 | 1,283,000 |
| EBITDA | 786,200 | 737,400 | -84,700 |
| Operating Income | 837,900 | 654,700 | -1,886,600 |
| Net Income | 1,318,800 | 339,900 | -2,238,900 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 11,926,200 | 11,653,300 | 9,687,200 |
| Total Liabilities | 7,492,800 | 7,144,500 | 7,588,300 |
| Total Stockholders Equity | 4,410,900 | 4,487,500 | 2,098,900 |
| Total Debt | 4,105,200 | 3,495,900 | 4,074,900 |
| Cash and Cash Equivalents | 302,400 | 357,300 | 584,500 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | -386,400 | 671,100 | -6,200 |
| Capital Expenditure | -133,900 | -67,900 | 0 |
| Free Cash Flow | -520,300 | 603,200 | -6,200 |
| Net Income | 1,417,300 | 401,700 | 0 |
| Net Change in Cash | -269,600 | 54,900 | 227,200 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 3,741,135.914 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 4,085,176.892 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 3,875,988.944 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 585,952.142 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 639,837.260 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 607,073.380 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 279,080.818 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 312,809.698 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 292,301.938 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 591,953.080 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 646,390.053 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 613,290.627 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 2.330 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 2.500 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 2.230 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 5 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid Financial Performance Metrics: FMC demonstrates robust financial health with consistent revenue and gross profit figures as per the latest income statements. Key metrics such as return on equity (ROE TTM) and return on invested capital (ROIC TTM) indicate efficient use of capital and strong profitability relative to industry peers.
- Strong Cash Flow Generation: The cash flow statements highlight positive net cash provided by operating activities and healthy free cash flow, reflecting FMC’s ability to generate cash to fund operations, reduce debt, or return value to shareholders through dividends (as evidenced by dividend yield TTM and last dividend data).
- Market Position and Scale: With a significant market capitalization and a presence in the [industryName] within the [sectorName], FMC benefits from economies of scale and a diversified product portfolio, as seen in revenue product segments data, enhancing its competitive edge.
- Operational Efficiency: High gross profit margin TTM and net profit margin TTM suggest effective cost management and pricing power, positioning FMC favorably against competitors in the [industryName].
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates FMC intrinsic value between $68.37 – $70.80 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about FMC valuation
Is FMC Corporation (FMC) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for FMC Corporation (FMC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is FMC a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether FMC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is FMC’s P/E ratio?
You can see FMC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for FMC?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is FMC a good long-term investment?
Whether FMC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
FMC
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
6.29
Trading Metrics:
| Open: | 10.91 | Previous Close: | 10.66 | |
| Day Low: | 10.78 | Day High: | 11.33 | |
| Year Low: | 9.95 | Year High: | 39.63 | |
| Price Avg 50: | 10.99 | Price Avg 200: | 13.54 | |
| Volume: | 2.354M | Average Volume: | 3.702M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeFMC full analysis
Welcome to MARKETSNAP’s SWOT analysis for FMC Corporation, a key player in the agricultural sciences space. If you’re a long-term investor looking to dig into a company that’s deeply tied to global food security and innovation, you’re in the right place. Today, we’re breaking down FMC’s strengths, weaknesses, opportunities, and threats, while weaving in the latest news, financials, and performance trends to give you a full picture of where this stock stands—and where it might be headed. Let’s dive in!…
